Literature DB >> 10494685

Percutaneous choledochoscopic treatment of intrahepatic stones, including management of associated biliary stenoses.

I Maetani1, J Ishiguro, S Ogawa, M Sato, Y Igarashi, Y Sakai.   

Abstract

BACKGROUND AND STUDY AIMS: Choledochoscopic lithotomy is a useful non-surgical treatment for intrahepatic stones. In patients with stenoses, the procedure often fails, and recurrence rates are high. PATIENTS AND METHODS: The efficacy and risks of choledochoscopic lithotomy using our procedure were investigated in 15 patients with intrahepatic stones, with and without strictures. Long-term follow-up results in patients after successful clearance were also reviewed. The follow-up period ranged from one month to 127 months (mean 75 months).
RESULTS: Complete removal of stones was achieved in a mean of 2.0 sessions in all cases. The relationship between the number of sessions and the presence of the stenosis was not significant. One patient (6.7%) who had recurrent stones after complete clearance was successfully treated by repeat choledochoscopy. With regard to the rate of recurrence, there was no difference between patients with stenosis and those without. There was no procedure-related mortality. The rate of procedure-related complications was 6.7%.
CONCLUSIONS: Choledochoscopic lithotomy for hepatolithiasis is an effective and safe procedure in most patients, even those with severe biliary stenosis. The choice of the appropriate route for lithotomy and appropriate management of stenoses offers a higher success rate and a lower rate of recurrence.

Entities:  

Mesh:

Year:  1999        PMID: 10494685     DOI: 10.1055/s-1999-40

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  1 in total

1.  Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis.

Authors:  Bong-Wan Kim; Hee-Jung Wang; Wook-Hwan Kim; Myung-Wook Kim
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.